[Form 4] McEwen Inc. Insider Trading Activity

Rhea-AI Filing Summary

McEwen Inc. director Dalia Nadine Asterbadi was granted a stock option for 10,000 shares of common stock with a $10.43 exercise price on 08/11/2025. The option vests in three equal annual installments beginning 08/11/2026 and is exercisable through 08/11/2030, and the reporting person is shown as the direct beneficial owner of 10,000 options following the transaction.

This grant ties a board member’s compensation to the company’s share performance and creates potential future dilution if the options are exercised, while the staged vesting supports retention over the next three years.

Positive

• 10,000-option grant aligns the director's incentives with shareholder value through equity compensation
• Three-equal-installment vesting beginning 08/11/2026 promotes retention over multiple years
• Direct beneficial ownership of the option position is clearly disclosed

Negative

• Options are unvested initially; the first vesting installment does not occur until 08/11/2026, so there is no immediate share ownership
• Potential dilution exists if the options are exercised prior to expiration on 08/11/2030

Insights

Securities Analyst

TL;DR: Director granted 10,000 options at $10.43, vesting over three years; a routine incentive award with limited immediate impact.

The option grant to a director for 10,000 shares with a $10.43 strike and a five-year exercise window is a standard equity-based retention tool. The three-equal-installment vesting beginning one year after grant aligns the director with long-term shareholder value rather than providing immediate dilution. For a typical public issuer, this size grant is unlikely to be material to equity metrics but is relevant for governance and compensation disclosure.

Corporate Governance Expert

TL;DR: Grant reflects common board compensation practice; vesting schedule supports retention but yields no immediate shareholding.

The award’s structure—10,000 options, $10.43 strike, vesting in three equal annual installments starting 08/11/2026, expiring 08/11/2030—matches common governance practices to link directors’ interests with long-term performance. Because the options are unvested initially, there is no immediate change in voting power or share ownership. The disclosure is complete regarding terms and ownership form, enabling transparent oversight of insider incentives.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Asterbadi Dalia Nadine

(Last) (First) (Middle)

C/O MCEWEN INC.

150 KING STREET WEST, SUITE 2800

(Street)

TORONTO A6 M5H 1J9

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
McEwen Inc. [ MUX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$10.43	08/11/2025		A		10,000		(1)	08/11/2030	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. The option vests in three equal annual installments, beginning August 11, 2026.

	/s/ Dalia Nadine Asterbadi	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did McEwen Inc. (MUX) disclose about insider option grants?

The filing reports a grant of 10,000 stock options to director Dalia Nadine Asterbadi with a $10.43 exercise price on 08/11/2025.

When do the options granted to the MUX director vest?

The options vest in three equal annual installments beginning on 08/11/2026.

How long are the granted options exercisable for MUX?

The options are exercisable through 08/11/2030, giving a five-year exercise window from grant date.

How many options does the reporting person beneficially own after the transaction?

Following the reported transaction, the reporting person beneficially owns 10,000 options as a direct owner.

What is the nature of the ownership form reported for the MUX option grant?

The filing indicates direct (D) ownership of the 10,000 options.